 This has led to the creation of a national consortium based at Einstein to study the genetics of individuals with disorders of sex development.Ostrer and his collaborators have studied the roles of common and rare genetic variants in the risk of developing cancer and adverse effects of cancer therapy.This has led to the development of ‘molecular signatures’ for prediction of cancer risk and adverse effects.